The foregoing data suggest that the antiproliferative action of the NK-1 receptor antagonists L-733,060, L-732,138, and aprepitant, once bound to the NK-1 receptors located in the tumor cells, most likely involves the interaction with a signal transduction pathway for apoptosis. Here, TACR1 is linked to neoplasm.